Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

Psychoneuroimmunology: Diabetes and Cancer

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pleural and Pericardial Infection Due to Cutibacterium acnes in a Splenectomized Patient: A Case Report of an Underreported Systemic Infection.

Cureus·2021

Same author

Antibiotic resistance.

Journal of infection and public health·2016

Same author

A link: Allergic rhinitis, Asthma & Systemic Lupus Erythematosus.

Autoimmunity reviews·2016

Same author

Review: Immunology of sinusitis, trauma, asthma, and sepsis.

Allergy & rhinology (Providence, R.I.)·2015

Same author

Role of mast cells in trauma and neuroinflammation in allergy immunology.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2015

Same author

Systemic lupus erythematosus and atherosclerosis: Review of the literature.

Autoimmunity reviews·2015

Search research articles

Related Experiment Video

Updated: May 8, 2026

Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

Alzheimer's disease and immunotherapy.

Jennifer Madeo¹, Marianne Frieri

¹Department of Medicine, Nassau University Medical Center, East Meadow, NY 11554, USA.

Aging and Disease

|August 13, 2013

Summary

Alzheimer's disease (AD) is a growing epidemic, with aging as a key risk factor. Immunotherapy offers a promising strategy to modify AD's course and improve cognition.

Area of Science:

Neuroscience
Gerontology
Immunology

Background:

Alzheimer's disease (AD) is the leading cause of dementia, characterized by progressive cognitive decline.
Aging is the primary risk factor for AD, influencing brain oxidative and inflammatory processes.
Current treatments for AD are not disease-modifying, highlighting the need for novel therapeutic strategies.

Purpose of the Study:

To review the relationship between aging physiology and Alzheimer's disease pathogenesis.
To explore immunotherapy as a potential disease-modifying treatment for AD.
To discuss current immunotherapy research, mechanisms, and future directions for AD.

Main Methods:

Literature review of aging, Alzheimer's disease, and immunotherapy.

Keywords:

Alzheimer’s disease immunosenescence immunotherapy monoclonal antibodies vaccination

More Related Videos

Delivery of Antibodies into the Murine Brain via Convection-enhanced Delivery

Delivery of Antibodies into the Murine Brain via Convection-enhanced Delivery

Published on: July 18, 2019

Related Experiment Videos

Last Updated: May 8, 2026

Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

Delivery of Antibodies into the Murine Brain via Convection-enhanced Delivery

Delivery of Antibodies into the Murine Brain via Convection-enhanced Delivery

Published on: July 18, 2019

Analysis of current clinical trials and research studies.

Synthesis of existing knowledge on AD pathogenesis and therapeutic interventions.

Main Results:

Aging significantly impacts brain health, increasing susceptibility to Alzheimer's disease.
Immunotherapy demonstrates potential for reducing AD pathology and enhancing cognitive function.
Ongoing clinical trials are evaluating various immunotherapy approaches for AD.

Conclusions:

Understanding the aging process is crucial for elucidating Alzheimer's disease development.
Immunotherapy presents a promising avenue for developing disease-modifying treatments for AD.
Further research and clinical trials are essential to optimize immunotherapy strategies for Alzheimer's disease.